Suppr超能文献

BG505 三聚体免疫复合物免疫诱导的抗体反应。

Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.

机构信息

Department of Medicine, University of California Irvine, School of Medicine, Irvine, California, USA.

Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.01188-19. Print 2019 Oct 15.

Abstract

Immune complex (IC) vaccines have been successfully used to increase immune responses against various pathogens, including HIV-1. Additionally, IC vaccines can induce qualitatively different antibody responses, with distinct antigenic specificities compared to the same antigens used alone. Here we measured the HIV-1-specific antibody responses in female New Zealand White rabbits after immunization with ICs made from BG505 SOSIP.664 trimers (BG505 trimers) and three rabbit monoclonal antibodies (MAbs) with different neutralization profiles. Two of the MAbs were specific for a hole in the glycan shield of the BG505 trimer, while the third, which bound less avidly, was specific for determinants at the gp41-gp120 interface. We found that immunization with one of the glycan-hole-specific ICs resulted in lower levels of trimer-binding antibodies compared to vaccination with the uncomplexed trimer, and that ICs made using either of the glycan-hole-specific MAbs resulted in lower rates of anti-trimer antibody decay. We concluded that ICs based on MAbs that bound to the immunodominant glycan hole epitope likely diverted antibody responses, to some extent, away from this site and to other regions of the trimer. However, this outcome was not accompanied by a widening of the breadth or an increase in the potency of neutralizing antibody responses compared with uncomplexed trimers. Immunodominant epitopes may suppress immune responses to more desirable determinants, such as those that elicit potentially protective neutralizing antibody responses. To overcome this problem, we attempted to mask immunodominant glycan holes by immunizing rabbits with ICs consisting of the BG505 SOSIP.664 gp140 trimer and MAbs that targeted the glycan holes. We found that IC vaccination likely diverted antibody responses, to some extent, away from the glycan holes and toward other regions of the trimer. IC vaccination resulted in slower decay of HIV-1-specific antibodies than did immunization with uncomplexed trimer. We did not observe a widening of the breadth or an increase in the potency of neutralizing antibody responses compared to uncomplexed trimers. Our results suggest that selective epitope dampening of BG505 trimers by ICs is rather ineffective. However, IC vaccination may represent a novel means of increasing the duration of vaccine-induced antibody responses.

摘要

免疫复合物 (IC) 疫苗已成功用于提高针对各种病原体(包括 HIV-1)的免疫反应。此外,IC 疫苗可以诱导与单独使用相同抗原相比具有不同抗原特异性的定性不同的抗体反应。在这里,我们测量了新西兰白兔在接种 BG505 SOSIP.664 三聚体(BG505 三聚体)和三种具有不同中和谱的兔单克隆抗体(mAb)制成的 IC 后的 HIV-1 特异性抗体反应。两种 mAb 特异性针对 BG505 三聚体糖罩中的一个孔,而第三种结合亲和力较低的 mAb 特异性针对 gp41-gp120 界面上的决定簇。我们发现,与接种未复合三聚体相比,接种一种糖孔特异性 IC 会导致三聚体结合抗体水平降低,并且使用任何一种糖孔特异性 mAb 制成的 IC 都会导致抗三聚体抗体衰减率降低。我们得出结论,基于与免疫优势糖孔表位结合的 mAb 的 IC 可能在某种程度上将抗体反应从该部位转移到三聚体的其他区域。然而,与未复合三聚体相比,这一结果并没有伴随着中和抗体反应的广度或效力的扩大。免疫显性表位可能会抑制对更理想决定簇的免疫反应,例如那些引发潜在保护性中和抗体反应的决定簇。为了克服这个问题,我们试图通过用包含 BG505 SOSIP.664 gp140 三聚体和针对糖孔的 mAb 的 IC 免疫兔子来掩盖免疫显性糖孔。我们发现,IC 疫苗接种可能在某种程度上将抗体反应从糖孔转移到三聚体的其他区域。IC 疫苗接种导致 HIV-1 特异性抗体的衰减速度比接种未复合三聚体慢。与未复合三聚体相比,我们没有观察到中和抗体反应的广度或效力的扩大。我们的结果表明,通过 IC 对 BG505 三聚体进行选择性表位抑制的效果相当差。然而,IC 疫苗接种可能代表一种增加疫苗诱导的抗体反应持续时间的新方法。

相似文献

1
Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.01188-19. Print 2019 Oct 15.
4
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
PLoS Pathog. 2021 Aug 25;17(8):e1009736. doi: 10.1371/journal.ppat.1009736. eCollection 2021 Aug.
5
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
PLoS Pathog. 2018 Feb 23;14(2):e1006913. doi: 10.1371/journal.ppat.1006913. eCollection 2018 Feb.
8
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
PLoS Pathog. 2021 Feb 8;17(2):e1009257. doi: 10.1371/journal.ppat.1009257. eCollection 2021 Feb.
9
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
J Virol. 2022 Jan 12;96(1):e0155221. doi: 10.1128/JVI.01552-21. Epub 2021 Oct 20.

引用本文的文献

3
Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1.
Front Immunol. 2023 Oct 3;14:1271686. doi: 10.3389/fimmu.2023.1271686. eCollection 2023.
5
A diverse collection of B cells responded to HIV infection in infant BG505.
Cell Rep Med. 2021 Jun 15;2(6):100314. doi: 10.1016/j.xcrm.2021.100314.
6
Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.
mBio. 2021 Jun 29;12(3):e0042921. doi: 10.1128/mBio.00429-21. Epub 2021 Jun 22.
7
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
PLoS Pathog. 2021 Feb 8;17(2):e1009257. doi: 10.1371/journal.ppat.1009257. eCollection 2021 Feb.
8
Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases.
Vaccines (Basel). 2021 Feb 2;9(2):112. doi: 10.3390/vaccines9020112.
9
Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions.
Front Immunol. 2020 Oct 28;11:590780. doi: 10.3389/fimmu.2020.590780. eCollection 2020.

本文引用的文献

2
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines.
Front Immunol. 2018 Oct 26;9:2441. doi: 10.3389/fimmu.2018.02441. eCollection 2018.
3
B Cell Competition for Restricted T Cell Help Suppresses Rare-Epitope Responses.
Cell Rep. 2018 Oct 9;25(2):321-327.e3. doi: 10.1016/j.celrep.2018.09.029.
5
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
Immunity. 2018 Aug 21;49(2):301-311.e5. doi: 10.1016/j.immuni.2018.07.005. Epub 2018 Jul 31.
6
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
PLoS Pathog. 2018 Feb 23;14(2):e1006913. doi: 10.1371/journal.ppat.1006913. eCollection 2018 Feb.
9
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization.
Cell Rep. 2017 Aug 22;20(8):1805-1817. doi: 10.1016/j.celrep.2017.07.077.
10
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
PLoS One. 2017 Aug 9;12(8):e0181886. doi: 10.1371/journal.pone.0181886. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验